TrialHypertension research : official journal of the Japanese Society of Hypertension2019

Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension.

Charalampos Loutradis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.